Join a candid and informative discussion between two precision medicine experts who led one of the world’s largest precision medicine studies to date. They will share lessons learned and ...

Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.

ASX-Listed Biotech Firm Latest to Adopt a Bitcoin Strategy to Stay Afloat Opyl is betting on the so-called Bitcoin treasury strategy to navigate its financial chop and follow recent examples set by ...

Kymera shared news of changes to the Sanofi collaboration minutes after disclosing an oncology deal with Gilead. The Big Biotech has committed up to $85 million in upfront and potential option ...

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is one of the best biotech stocks to invest in now. On June 3, Amylyx Pharmaceuticals announced that the US FDA granted Fast Track designation to AMX0114.

Discover what makes Paris's biotech ecosystem so successful, as it just so happens to be one of the largest biotech clusters in Europe.